Here are five things to know:
1. The study evaluated data from 49 volunteers and tracked the entire passage of Check-Cap’s capsule system through the alimentary tract.
2. The system uses radio frequency telemetry and Check-Cap’s proprietary capsule position tracking system.
3. In the study, all capsules were swallowed naturally without adverse events, and there was a 100 percent capsule excretion rate.
4. The study results represent a preliminary analysis of the first patients evaluated in Check-Cap’s ongoing multi-center clinical evaluation.
5. The study aims to further evaluate the Check-Cap system’s efficacy in the detection of pre-cancerous polyps.
More articles on GI/endoscopy:
ACG elects Dr. Kenneth DeVault president: 5 things to know
Fujifilm Endoscopy introduces 4 additions to 500 series scope line
75% of patients prefer stool DNA testing for colorectal cancer screening over colonoscopy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
